Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury.
暂无分享,去创建一个
Frank D Sistare | Warren E Glaab | L. Lim | P. Garrett-engele | Jason M. Johnson | T. Fare | F. Sistare | O. Laterza | J. Sina | Jason M Johnson | K. Vlasakova | N. Muniappa | Wesley K. Tanaka | W. E. Glaab | Omar F Laterza | Philip W Garrett-Engele | Katerina Vlasakova | Lee Lim | Nagaraja Muniappa | Wesley K Tanaka | Joseph F Sina | Thomas L Fare | W. Tanaka | Lee P. Lim
[1] V. Arolt,et al. S100B in brain damage and neurodegeneration , 2003, Microscopy research and technique.
[2] A. Singer,et al. The temporal profile of increased transaminase levels in patients with acetaminophen-induced liver dysfunction. , 1995, Annals of emergency medicine.
[3] S. Chandor. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics , 2006 .
[4] Jin-Moo Lee,et al. Identification of novel brain biomarkers. , 2006, Clinical chemistry.
[5] M. Pelsers,et al. Detection of brain injury by fatty acid-binding proteins , 2005, Clinical chemistry and laboratory medicine.
[6] J. Lott,et al. Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring , 2000, Clinical chemistry.
[7] Edward R. Ashwood,et al. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics , 2005 .
[8] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[9] V. Ambros,et al. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation , 2004, Genome Biology.
[10] L. Hood,et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury , 2009, Proceedings of the National Academy of Sciences.
[11] Dawn G Goodman,et al. Best Practices Guideline: Toxicologic Histopathology , 2004, Toxicologic pathology.
[12] H. Zimmerman,et al. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure , 1995, Hepatology.
[13] L. Stead,et al. Neuron-Specific Enolase as a Marker for Acute Ischemic Stroke: A Systematic Review , 2005, Cerebrovascular Diseases.
[14] H. Hårdemark,et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. , 1987, Stroke.
[15] Yu Liang,et al. BMC Genomics , 2007 .
[16] Manfred Herrmann,et al. Release of Glial Tissue–Specific Proteins After Acute Stroke: A Comparative Analysis of Serum Concentrations of Protein S-100B and Glial Fibrillary Acidic Protein , 2000, Stroke.
[17] J. Vaage,et al. Biochemical markers of neurologic injury in cardiac surgery: the rise and fall of S100beta. , 2001, The Journal of thoracic and cardiovascular surgery.
[18] K. Ishak,et al. Ticrynafen‐Associated Hepatic Injury: Analysis of 340 Cases , 1984, Hepatology.
[19] Alicja R Rudnicka,et al. Statin safety: a systematic review. , 2006, The American journal of cardiology.
[20] J. Broderick,et al. Association of Serial Biochemical Markers With Acute Ischemic Stroke: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study , 2006, Stroke.
[21] J. Lott,et al. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. , 2000, Clinical chemistry.
[22] Brian S. Roberts,et al. Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs. , 2005, RNA.
[23] Beate Wittbrodt,et al. Differences in vertebrate microRNA expression , 2006, Proceedings of the National Academy of Sciences.
[24] P. Weinstein,et al. Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.
[25] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[26] T. Tuschl,et al. Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.